Treatment of patients, who have Mucopolysaccharidosis Type I, receiving pentosan polysulfate subcutaneous injections weekly Treatment of patients, who have Mucopolysaccharidosis Type I, receiving pentosanpolysulfate subcutan ...
An open label, randomized study to investigate the safety of weekly pentosan polysulfate injections in adult patients with Mucopolysaccharidosis Type I receiving enzyme replacement therapy. An open label, randomized study to investigate the safety of weekly pentosanpolysulfate injections i ...
Mucopolysaccharidosis type I (alpha-L-Iduronidase deficiency) MedDRA version: 17.0;Level: LLT;Classification code 10056888;Term: Mucopolysaccharidosis IS;System Organ Class: 100000004850 MedDRA version: 17.0;Classification code 10056887;Term: Mucopolysaccharidosis IH/S;Classification code 10028094;Term: Mucopolysaccharidosis IH;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18] Mucopolysaccharidosis type I (alpha-L-Iduronidase deficiency) MedDRA version: 17.0;Level: LLT;Classi ...
Trade Name: Pentosan Polysulfat SP 54® injection solution Product Name: PentosanPolysulphateSP54® INN or Proposed INN: PENTOSAN POLYSULFATE SODIUM Other descriptive name: PentosanPolysulphateSP54Trade Name: PentosanPolysulfat SP 54® injection solution Product Name: PentosanPolysulphateSP54® INN ...